Mestinon 180 mg Extended Release Oral Tablet
RxNorm 903849
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 903849 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Mestinon 180 mg Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Mestinon 180 mg Extended Release Oral Tablet
(Atom ID: 6371961)
SYPrescribable
Synonym (SY):
Mestinon 180 mg Extended Release Oral Tablet
(Atom ID: 6358239)
SYPrescribable
Synonym (SY):
Mestinon 180 mg Timespan Tablet
(Atom ID: 3065525)
SBDPrescribable
Semantic Branded Drug (SBD):
Pyridostigmine bromide 180 mg Extended Release Oral Tablet [Mestinon]
(Atom ID: 12370935)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
PyRIDostigmine bromide 180 mg Extended Release Oral Tablet [Mestinon]
(Atom ID: 12815371)
Patient Education
Pyridostigmine
Pyridostigmine is used to decrease muscle weakness resulting from myasthenia gravis.
[Learn More]
* Please review the disclaimer below.